~~<i id='8C72DEB132'><strike id='8C72DEB132'><tt id='8C72DEB132'><pre id='8C72DEB132'></pre></tt></strike></i>~~

Home» leisure time» fashion

fashion

author：explore 2025-09-28 11:51:26 Page View：46941

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc
Next article： As demand for Covid shots wanes, Moderna seeks its next success

leisure time

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

A bus careens into a gulch in southern Mexico, leaving 27 people dead

MEXICOCITY--Apassengerbuslostcontrolandveeredoffaroadandintoa75-foot-deep(25meter-deep)gullyinsouthe

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

CMS should re

AdobeIn2011,theCentersforMedicareandMedicaidServicescreatedtheannualwellnessvisit(AWV),anewvisittype